Nemolizumab Demonstrates Marked Efficacy in Challenging Chronic Pruritus: A Real-world Multicenter Case Series
{{output}}
Objective: Chronic pruritus significantly impacts quality of life and remains challenging to manage, particularly in patients unresponsive to systemic therapies. Nemolizumab, a monoclonal antibody targeting the interleukin (IL)-3... ...
